News for Bioxyne Limited (BXN.AX)

Bioxyne (ASX: BXN) has received certificates of Good Manufacturing Practice (GMP) compliance under mutual recognition agreements with five countries. The

Diversified health products company Bioxyne (ASX: BXN) has upgraded its full-year revenue guidance for financial year 2025 by $3 million to $28m. The

The benchmark Aussie index has ended Friday slightly higher after mining stocks fell despite a strong morning session.

The ASX200 closed the day down about a per cent – with nearly all sectors in the red – as the market awaits Australia’s interest rates decision tomorrow.

The ASX200 has dropped further than futures had tipped. Down more than a per cent. The only sectors in the green are IT.

Bioxyne (ASX:BXN) subsidiary Breathe Life Sciences (BLS) has secured a GMP license to manufacture medical cannabis.

In recent years, there has been a notable shift in consumer preferences towards alternative beverages that offer calming effects without the downsides associated with alcohol consumption.

The ASX closed down 0.58 per cent. All sectors except communications traded down.

The ASX200 closed up 0.38 per cent today. Energy and materials stocks were the strongest performers.

The ASX 200 is down nearly 0.5 per cent at market close, declining throughout the day after a strong start.

Rise and Shine: Everything you need to know before the ASX opens

Telehealth, mental health and aged care stocks rallied on Wednesday following the Budget announcement which include billions for healthcare.

The ASX wandered to a -0.25% close today as banks and oil stocks dragged the market down, leaving Magnum Mining to win the day on +44.1%

The ASX has dipped 0.2% this morning as the US braces for CPI data, while Magnum's gone flying thanks to a huge offtake deal with Mitsubishi.

Magnum Mining & Exploration (ASX:MGU) has inked a MOU with Mitsubishi for offtake of all products from the Buena Vista Green Iron Project.

The ASX stumbled this morning, dragged down by Financials in the wake of a US rate rise, but Caspin's REE find is making the market happy.

The ASX lost ground this morning, after banking jitters hit Wall Street and Aussies woke up to the memory of yesterday's RBA donkey-punch.

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

The ASX rallied from a -0.5% dip to hit lunch flat, CPI data hits market expectations while Brookfield's oil reserve looks better than ever.